EP2121985A4 - Genetics variants associated with hiv disease restriction - Google Patents

Genetics variants associated with hiv disease restriction

Info

Publication number
EP2121985A4
EP2121985A4 EP08727164A EP08727164A EP2121985A4 EP 2121985 A4 EP2121985 A4 EP 2121985A4 EP 08727164 A EP08727164 A EP 08727164A EP 08727164 A EP08727164 A EP 08727164A EP 2121985 A4 EP2121985 A4 EP 2121985A4
Authority
EP
European Patent Office
Prior art keywords
hiv disease
variants associated
restriction
genetics
genetics variants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08727164A
Other languages
German (de)
French (fr)
Other versions
EP2121985A2 (en
Inventor
David B Goldstein
Amalio Telenti
Jacques Fellay
Kevin V Shianna
Dongliang Ge
Barton F Haynes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Lausanne
Duke University
Original Assignee
Universite de Lausanne
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Lausanne, Duke University filed Critical Universite de Lausanne
Publication of EP2121985A2 publication Critical patent/EP2121985A2/en
Publication of EP2121985A4 publication Critical patent/EP2121985A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP08727164A 2007-03-27 2008-03-27 Genetics variants associated with hiv disease restriction Withdrawn EP2121985A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90727107P 2007-03-27 2007-03-27
US92943207P 2007-06-27 2007-06-27
PCT/US2008/003964 WO2008118469A2 (en) 2007-03-27 2008-03-27 Genetics variants associated with hiv disease restriction

Publications (2)

Publication Number Publication Date
EP2121985A2 EP2121985A2 (en) 2009-11-25
EP2121985A4 true EP2121985A4 (en) 2011-01-05

Family

ID=39789200

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08727164A Withdrawn EP2121985A4 (en) 2007-03-27 2008-03-27 Genetics variants associated with hiv disease restriction

Country Status (5)

Country Link
EP (1) EP2121985A4 (en)
JP (1) JP2010522560A (en)
AU (1) AU2008231305A1 (en)
CA (1) CA2680834A1 (en)
WO (1) WO2008118469A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105316417B (en) * 2015-11-27 2018-11-30 北京泱深生物信息技术有限公司 The diagnosis and treatment target of ZNRD1 gene and its expression product as intracranial aneurysm
EP3555303B1 (en) * 2016-12-14 2022-12-21 Merck Sharp & Dohme Corp. Human genetic markers associated with response to treatments that target clostridium difficile toxin b

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130152A2 (en) * 2004-11-26 2006-12-07 Board Of Regents, University Of Texas System Methods and compositions for correlating ccl3l1/ccr5 genotypes with disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006130152A2 (en) * 2004-11-26 2006-12-07 Board Of Regents, University Of Texas System Methods and compositions for correlating ccl3l1/ccr5 genotypes with disorders

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
HOGAN C M ET AL: "Host determinants in HIV infection and disease: Part 2: Genetic factors and implications for antiretroviral therapeutics", ANNALS OF INTERNAL MEDICINE, vol. 134, no. 10, 15 May 2001 (2001-05-15), NEW YORK, NY; US, pages 978 - 996, XP002276751, ISSN: 0003-4819 *
KIEPIELA PHOTINI ET AL: "Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.", NATURE, vol. 432, no. 7018, 9 December 2004 (2004-12-09), pages 769 - 774, XP002606951, ISSN: 1476-4687 *
MOORE C B ET AL: "Evidence of HIV-1 adaptation to HLA restricted immune responses at a population level", SCIENCE, vol. 296, 24 May 2002 (2002-05-24), AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, pages 1439 - 1443, XP002986696, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.1069660 *
MUEHL THORSTEN ET AL: "MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys", JOURNAL OF IMMUNOLOGY, vol. 169, no. 6, 15 September 2002 (2002-09-15), pages 3438 - 3446, XP002606948, ISSN: 0022-1767 *
SHAO WENSHUO ET AL: "Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression", AIDS (HAGERSTOWN), vol. 20, no. 12, August 2006 (2006-08-01), pages 1583 - 1590, XP002606947, ISSN: 0269-9370 *
TANG JIANMING ET AL: "Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.", JOURNAL OF VIROLOGY, vol. 76, no. 16, August 2002 (2002-08-01), pages 8276 - 8284, XP002606952, ISSN: 0022-538X *
TELENTI AMALIO ET AL: "Genomics meets HIV-1.", NATURE REVIEWS. MICROBIOLOGY, vol. 4, no. 11, November 2006 (2006-11-01), pages 865 - 873, XP002606946, ISSN: 1740-1534 *
TRACHTENBERG ELIZABETH ET AL: "Advantage of rare HLA supertype in HIV disease progression.", NATURE MEDICINE, vol. 9, no. 7, July 2003 (2003-07-01), pages 928 - 935, XP002606950, ISSN: 1078-8956 *

Also Published As

Publication number Publication date
CA2680834A1 (en) 2008-10-02
WO2008118469A3 (en) 2008-12-24
AU2008231305A1 (en) 2008-10-02
WO2008118469A2 (en) 2008-10-02
EP2121985A2 (en) 2009-11-25
JP2010522560A (en) 2010-07-08

Similar Documents

Publication Publication Date Title
HK1137480A1 (en) Disease resistant plants
PL2131830T3 (en) Pharmaceutical form with impeded abuse
PL2514818T3 (en) Glucoamylase variants
IL200453A0 (en) Genetic susceptibility variants associated with cardiovascular disease
PL2222842T3 (en) Glucoamylase variants with altered properties
GB0720730D0 (en) Soother
EP2212471A4 (en) Forming section
EP2156167A4 (en) Biochip
GB2467456B (en) Distributed arbitration
PL2455476T3 (en) Disease resistant plants
GB0721332D0 (en) Medicaments
IL197883A0 (en) Combination drug
EP2190608A4 (en) Can bottom forming assembly
IL193760A0 (en) Disease resistant plants
EP2121985A4 (en) Genetics variants associated with hiv disease restriction
GB2451150B (en) Lifts
GB0717450D0 (en) Medicament
GB0721333D0 (en) Medicaments
GB0806180D0 (en) Improved structure
KG1098C1 (en) Towel-drying construction
GB0709404D0 (en) Sanitiser
GB0714114D0 (en) Injectable medications
GB0714922D0 (en) Preventing reflux
GB0704076D0 (en) Bee two
GB0721174D0 (en) Lift mechanisms

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090928

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20101206

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110504